All Stories

  1. Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections
  2. Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance
  3. If Not Now, When? Nonserotype Pneumococcal Protein Vaccines
  4. Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid
  5. Prophylactic inhibition of colonization by Streptococcus pneumoniae with the secondary bile acid metabolite deoxycholic acid
  6. Otitis Media and Ear Infections: Bacteria
  7. Hydrogen Peroxide Production by Streptococcus pneumoniae Results in Alpha-hemolysis by Oxidation of Oxy-hemoglobin to Met-hemoglobin
  8. Hydrogen peroxide production by Streptococcus pneumoniae results in alpha-hemolysis by oxidation of oxy-hemoglobin to met-hemoglobin
  9. Mucosal Vaccines for Streptococcus pneumoniae
  10. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA
  11. Selective pressure: Rise of the nonencapsulated pneumococcus
  12. Pulmonary Disease Associated With Nonencapsulated Streptococcus pneumoniae
  13. Pseudomonas aeruginosa and Streptococcus pneumoniae coinfection
  14. Invasive Potential of Nonencapsulated Streptococcus pneumoniae
  15. Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae
  16. Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?
  17. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media
  18. NonencapsulatedStreptococcus pneumoniae: Emergence and Pathogenesis
  19. Nonencapsulated Streptococcus pneumoniae as a cause of chronic adenoiditis
  20. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization
  21. Nonencapsulated Streptococcus pneumoniae Cause Acute Otitis Media in the Chinchilla That Is Enhanced by Pneumococcal Surface Protein K
  22. Choline-Binding Proteins
  23. Draft Genome Sequences of Five Multilocus Sequence Types of Nonencapsulated Streptococcus pneumoniae
  24. The Cholesterol-Dependent Cytolysin Pneumolysin from Streptococcus pneumoniae Binds to Lipid Raft Microdomains in Human Corneal Epithelial Cells
  25. Serine Protease PKF of Acinetobacter baumannii Results in Serum Resistance and Suppression of Biofilm Formation
  26. PspK of Streptococcus pneumoniae Increases Adherence to Epithelial Cells and Enhances Nasopharyngeal Colonization
  27. 66-P
  28. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis
  29. Serum resistance and biofilm formation in clinical isolates ofAcinetobacter baumannii
  30. Cross-Sectional Study of Nasopharyngeal Carriage of Streptococcus pneumoniae in Human Immunodeficiency Virus-Infected Adults in the Conjugate Vaccine Era
  31. Protection from Streptococcus pneumoniae Keratitis by Passive Immunization with Pneumolysin Antiserum
  32. Factor H Binding to PspC of Streptococcus pneumoniae Increases Adherence to Human Cell Lines In Vitro and Enhances Invasion of Mouse Lungs In Vivo
  33. Characterization of Streptococcus pneumoniae isolated from children with otitis media
  34. Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae
  35. Localization of PcsB of Streptococcus pneumoniae and Its Differential Expression in Response to Stress
  36. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA
  37. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin
  38. Tex, a putative transcriptional accessory factor, is involved in pathogen fitness in Streptococcus pneumoniae
  39. Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H
  40. 57-P
  41. In Vivo Binding of Complement Regulator Factor H by Streptococcus pneumoniae
  42. THP-1 Monocytes Up-Regulate Intercellular Adhesion Molecule 1 in Response to Pneumolysin from Streptococcus pneumoniae
  43. Impact of peripheral blood IL-18 gene early expression on kidney allograft long-term outcome
  44. Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H
  45. Pneumococcal Disease
  46. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  47. Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated by Streptococcus pneumoniae
  48. Genetic Immunization with the Region Encoding the α-Helical Domain of PspA Elicits Protective Immunity againstStreptococcus pneumoniae
  49. Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae
  50. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae
  51. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6BStreptococcus pneumoniae
  52. Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in Mice
  53. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
  54. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae
  55. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae
  56. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies
  57. Role of Pneumococcal Surface Protein A in the Virulence of Streptococcus pneumoniae
  58. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies
  59. Monoclonal Antibodies against Surface Components of Streptococcus pneumoniae
  60. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae